URL has been copied successfully!
Enlivex Ltd. (NASDAQ:ENLV), a quality longevity company powered by a prediction markets treasury, reported net income of $1.23 billion and diluted EPS of $25.48 for fiscal year 2025, with total treasury and treasury-related derivative assets of $2.31 billion. The company said much of the profit during the year was driven by appreciation in treasury and treasury-related derivative assets, underscoring the success of its dual business model. Enlivex ended the year with total shareholders’ equity of about $1.93 billion and cash, cash equivalents and short-term investments in digital assets of $30 million.
Enlivex Dual Engine Strategy
Unlike some other biotech companies, Enlivex has adopted a …
Please follow us:
This post was originally published here
